SP Gonadotropin 1000 IU SP Laboratories | TPT-0300

Description:

SP Gonadotropin 1000 is a human chorionic gonadotropin (hCG) medication containing chorionic gonadotropin derived from natural (human) origin in 1000 IU vials. Chorionic gonadotropin is a polypeptide hormone commonly found in a woman's body during the first months of pregnancy. It is synthesized in the syncytiotrophoblast cells of the placenta and is responsible for increasing the production of progesterone, a hormone that supports pregnancy. Chorionic gonadotropin is present in significant amounts only during pregnancy and is used as an indicator of pregnancy by standard over-the-counter pregnancy testing kits. The levels of chorionic gonadotropin in the blood become noticeable as early as seven days after ovulation and increase evenly to a peak after about two to three months of pregnancy. Thereafter

hCG does not have significant thyroid stimulating activity. This is particularly pointed out because hCG was once widely used to treat obesity.

Human chorionic gonadotropin is usually administered intramuscularly (IM). A subcutaneous route of administration is also used, which is considered therapeutically equivalent to intramuscular injections. Peak concentrations of chorionic gonadotropin are observed approximately 6 hours after intramuscular injection and 16-20 hours after subcutaneous injection.

When used for the treatment of hypogonadotropic hypogonadism, current FDA-approved protocols recommend either a short 6-week program or a long-term program of up to 1 year, depending on the individual needs of the patient. Recommendations for short-term use recommend injecting 500 to 1000 units 3 times a week for 3 weeks, and then at the same dose twice a week for 3 weeks. Long-term recommendations call for the administration of 4,000 units 3 times a week for 6-9 months, after which the dosage is reduced to 2,000 units 3 times a week for an additional 3 months. Bodybuilders and athletes use hCG either during the course to maintain testicular integrity while taking steroids, or after the course to restore hormonal homeostasis more quickly. Both types of use are considered effective when applied correctly.

Human chorionic gonadotropin is often used with other medications as part of an advanced post-course therapy (PCT) program aimed at faster recovery of endogenous testosterone production at the end of a steroid cycle. Restoring endogenous testosterone production is a special task at the end of each cycle, when subnormal androgen levels (due to steroid-induced suppression) can be very costly for the body. The main concern is the effect of cortisol, which is largely balanced by the action of androgens. Cortisol sends the opposite signal to the muscles than testosterone, or breaks down the protein in the cell. If you don't control your low testosterone levels, cortisol can quickly strip you of most of your new muscle mass. Post-course HCG use protocols usually require the administration of 2000-3000 units every 2 or 3 days, taken no longer than 2 or 3 weeks. If used for too long or in too high doses, the drug can actually reduce the sensitivity of Leydig cells to luteinizing hormone, making it even more difficult to return to homeostasis. For a more complete understanding of the role of hCG in a proper hormonal recovery program, refer to the "Post-cycle Therapy" section of this book.